In addition to this, the circulating Gas6 and sAxl plasma levels were slightly increased in mild ILD patients compared to patients without ILD, possibly reflecting this system as either a marker of progression to fibrosis or an indicator of a dysregulated control of inflammation [159]. This evidence concerns the gene GAS6 and interstitial lung disease.